Trimipramine Maleate and Monoamine Oxidase Inhibitors (MAOIs)

In this article, we will discuss Trimipramine Maleate and Monoamine Oxidase Inhibitors (MAOIs). So, let’s get started.

Trimipramine Maleate and Monoamine Oxidase Inhibitors (MAOIs)

The use of MAOIs intended to treat psychiatric disorders with Trimipramine Maleate or within 14 days of stopping treatment with Trimipramine Maleate is contraindicated because of an increased risk of serotonin syndrome. The use of Trimipramine Maleate within 14 days of stopping an MAOI intended to treat psychiatric disorders is also
contraindicated.

Starting Trimipramine Maleate in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.